Respivert

Small molecule drugs for patients with Chronic Obstructive Pulmonary Disease, Cystic Fibrosis and severe asthma.

placeLondon, England, United Kingdom calendar_todayFounded 2007 groups1 employees language respivert.com

Registered entities

Innovation

74 patent families (35 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 10,174 times.

YearFilings
201527
201631
201724
201819
201912
20207
20213
20223
20233
20241
20251
20261

Investor mix

4 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital4100%
Coming soon